Mission Statement Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.

Synapse to Society: Addiction Medicine State of the Art 2015

October 21-24, 2015
Hyatt Regency, San Francisco Airport

Keep up with the latest advances in addiction medicine at Synapse to Society: Addiction Medicine State of the Art 2015 conference. The conference will cover the latest clinical and scientific information in the field of addiction medicine focusing on practical applications and presented by leading experts. 

Printable conference brochure

Exhibitor information and registration (online)
Printable exhibitor registration form (pdf)‚Äč


Continuing Medical Education

Online Version of the 2014 Addiction Medicine Review Course and ABAM Certification Exam Preparation Track

What people are saying about the 2014 Review Course:

  • “Absolutely outstanding in terms of material presented. Found the conference stimulating, motivating and thought provoking. I feel the energy to change and educate the world about this epidemic of addiction that affects all of us.”
  • “One of the best conferences ever attended; well organized, excellent and knowledgeable presenters, and friendly staff.  It helped me to prepare for the exam and now I feel more confident to take the test.”

More information and purchase online course
Purchase Conference Syllabus and Addiction Medicine Study Guide


CSAM Receives Accreditation with Commendation from IMQ/CMA

On November, 20, 2014, CSAM's education program was awarded a 6-year accreditation with commendation by the California Medical Association / Institute for Medical Quality.  Six-year accreditation is the highest accreditation awarded by the CMA/IMQ and is awarded to only a small percentage of CME providers. 

Public Policy

Minimum Insurance Benefits for Medically-Assisted Treatment of Opioid Dependence

CSAM’s Consumer Guide and Scorecard rating Covered California health plans on coverage for addiction treatment, published last year disclosed that not a single health plan offered the minimum health insurance coverage for medically-assisted treatment of opioid dependence. In most plans physicians were not allowed to choose the appropriate medication, with plans offering either methadone OR buprenorphine. Many plans also required physicians to provide extensive paperwork every month for on-going treatment.  CSAM’s Committee on opioids will be advocating that ALL insurance plans meet these standards by meeting with insurance regulators and insurance companies.  As part of this Committee members Tauheed Zaman, MD and Joan Striebel, MD drafted a report that describes the minimum benefits insurance companies should provide to meet standards of evidence-based practice.